INTRODUCTION
The innate immune system utilizes pattern recognition receptors (PRRs) on host cells to detect signs of pathogen infection and cellular danger signals in the extracellular, endosomal and cytosolic milieus. 1 Sensing of non-self pathogen products called pathogen-associated molecular patterns (PAMPs) by PRRs triggers downstream signaling to elicit an innate immune response and to further activate the adaptive immune system. Nucleic acids are central to the replication and propagation of most if not all pathogens; therefore, the detection of aberrant DNA and RNA has evolved as a general strategy of host defense. Previous studies have suggested that endosomal nucleic acids are detected by a subset of Toll-like receptors (TLR3, TLR7, TLR8, TLR9 and TLR13), [2] [3] [4] whereas viral RNA activates the family of RIG-I-like receptors (RLRs) to produce type I interferons (IFNs) and proinflammatory cytokines. 1 DNA was known to be a potent immune stimulant long before it was shown to be the genetic material. Inappropriately located DNA is a sign of danger for the host. The danger can be derived from microbial DNA after infection or cellular damage and even apoptosis that causes DNA to leak into the cytoplasm from the nucleus or mitochondria. Several proteins have been reported to recognize cytosolic DNA in mammalian cells, including DAI, 5 DDX41, 6 IFI16, 7 Sox2 8 and LSM14A. 9 In addition, AIM2, a member of the Pyrin family, detects cytosolic DNA in myeloid cells to activate the inflammasome pathway, which leads to pyroptosis and the maturation of inflammatory cytokines, including interleukin-1β (IL-1β) and IL-18. [10] [11] [12] [13] Several studies have reported a key role for the membrane protein MITA (also called STING, ERIS and MPYS) in cytosolic DNA-induced type I IFN production. [14] [15] [16] [17] It has also been shown that MITA can directly bind to cyclic dinucleotides (CDNs) from bacteria. 18, 19 However, how MITA is activated by cytosolic DNA has remained unclear until recently. By biochemical purification coupled with quantitative mass spectrometry, a nucleotidyltransferase called cyclic GMP-AMP (cGAMP) synthase (cGAS), has been identified as a new cytoplasmic DNA sensor in various cell types and in mice. 20, 21 Gene-deletion studies have suggested that cGAS is essential for innate immunity against various DNA viruses in cells and mice. 22 After recognition of cytosolic DNA, cGAS catalyzes the synthesis of cGAMP from ATP and GTP, which then acts as a second messenger to bind to MITA and further activates MITA-mediated downstream signaling, leading to the induction of downstream antiviral genes. These findings suggest that the cGAS-cGAMP-MITA pathways are essential for cytosolic DNA-triggered innate immune responses.
THE cGAS-MITA SIGNALING PATHWAYS
Almost all cytosolic DNA sensors converge on the endoplasmic reticulum (ER)-associated adapter protein MITA, which is a 379-aa protein consisting of several transmembrane domains. MITA is expressed in various cell types, such as endothelial, epithelial cells and hematopoietic cells. [14] [15] [16] [17] Previous studies have clearly established that MITA mediates the innate immune response to invading DNA viruses, as well as to certain RNA viruses and bacteria and to transfected DNA. 14, 15, 17, 23 In addition to being an adapter, subsequent studies have demonstrated that MITA also acts as an sensor for CDNs, such as cyclic di-AMP (c-di-AMP) and cyclic di-GMP (c-di-GMP) derived from bacteria such as Listeria monocytogenes, 18, 19 and small molecules, such as DMXAA (5,6-dimethylxanthenone-4-acetic acid, Vadimezan) that exhibit immune modulatory activities through the induction of cytokines and disrupting tumor vascularization in mouse xenotransplantation models. [24] [25] [26] Furthermore, MITA has been reported to bind double-stranded DNA (dsDNA) directly, although the physiological relevance of this activity remains to be clarified. Recently, MITA has also been proposed to have a role in host sensing of virus-cell membrane fusion events. 27 A series of studies have established a model for cGAS-MITA-mediated signaling pathways. cGAS can recognize cytosolic DNA species and subsequently catalyze the synthesis of cGAMP from ATP and GTP, which contains one 2′,5′-phosphodiester linkage and a canonical 3′,5′-linkage (c[G (2′,5′)pA(3′,5′)p]). 21, 28, 29 Interestingly, a bioinformatic analysis has suggested that MITA evolved the ability to bind CDNs long before the catalytic activity of cGAS emerged in vertebrates, 30 which suggests the possible existence of CDNs independent of cGAS, such as bacterial c-di-AMP or c-di-GMP. This evolutionary strategy may contribute to direct sensing by MITA of microbial components that are not detected by cGAS. A structural analysis has shown that a single cGAMP generated by cGAS binds to two molecules of MITA in the ER. This event probably induces changes in MITA conformation, leading to trafficking events that result in the translocation of the MITA-TBK1 complex to perinuclear microsomes or punctate structures in the cell. These trafficking events are required to deliver TBK1 to endolysosomal compartments, where it phosphorylates the transcription factors IRF3 and NF-κB. The activated transcription factors translocate into the nucleus to initiate transcription of downstream antiviral genes.
Although early studies have suggested that MITA is not involved in signaling triggered by other DNA sensors, such as TLR9 and AIM2, 23, 31, 32 increasing evidence suggests that MITA-mediated signaling cooperates or competes with others involved in innate immune responses. MITA-mediated signaling potently affects the production of the precursors of IL-1β and other inflammatory cytokines and is involved in self-DNAmediated inflammation disease, 33 indicating that STING may act in concert with the AIM2 pathway. However, another study has demonstrated that MITA-mediated signaling is enhanced in AIM2 inflammasome-deficient macrophages and dendritic cells (DCs), and that inhibition of caspase-1 is responsible for this effect. 34 It has also been shown that MITA can recruit STAT6 to the ER after viral infection, resulting in phosphorylation of STAT6 on S407 and Y641 by TBK1 and another unidentified tyrosine kinase, respectively, and in homodimerization and nuclear translocation of STAT6, which specifically initiates transcription of CCL2, CCL20 and CCL26. 35 In addition, it has been shown that MITA can inhibit dsDNAtriggered activation of JAK-STAT1 signaling by activating the phosphatases SHP1 and SHP2. 36 In addition to a critical role in DNA-triggered innate immune responses, MITA also has important roles in host defense against certain RNA viruses in specific cell types. It has been shown that knockdown of MITA impairs Sendai virus (SeV)-and vesicular stomatitis virus (VSV)-induced IFN production in human cell lines and primary macrophage and DCs. 15, 17, 37 Genetic studies have indicated that MITA deficiency renders embryonic fibroblasts highly susceptible to VSV, but less susceptibility was observed in mouse bone marrow derived dendritic cells or bone marrow derived macrophages. 14 MITA-deficient mice were impaired in type I IFN induction and highly susceptible to lethal infection with VSV, but not encephalomyocarditis virus (EMCV). 23 Additional studies have also demonstrated that MITA modulates immune responses to dengue virus, 38 West Nile virus 39 and Japanese encephalitis virus, 40 but not to those sensed exclusively by MDA-5, such as EMCV. Mechanistically, it has been demonstrated that MITA is associated with VISA and recruits TBK1 and IRF3 to the VISAassociated complex upon viral infection. 17 Several recent studies support the hypothesis that there is an additional RIG-I-independent method by which MITA is important for sensing RNA viruses. 27, 41, 42 It is possible that MITA exerts this role through its translocation function, sensing of nucleic acidindependent virus-cell membrane fusion events, or even autophagy. In addition, cGAS has also been reported to have a role in the host defense against RNA viruses similar to the nucleotidyltransferase (NTase) family member 2′-5′-oligoadenylate synthase (OAS1), 41, 43 although the mechanism remains unclear.
cGAS-MITA SIGNALING AND DISEASES Normally, DNA is confined within the nucleus and mitochondria, away from cytosolic DNA sensors. DNA dislocation in the cytoplasm, such as after microbial infection or cellular damage, is a sign of danger. In this scenario, DNA can result in certain autoimmune diseases, such as systemic lupus erythematosus (SLE) and Aicardi-Goutieres syndrome (AGS). The host also has evolved protection mechanisms to avoid this type of situation. DNases distributed in the cytosol, lysosomes and ER can detect and digest the mislocalized or unwanted DNA. Animal models with defects in DNases exhibit lethal inflammatory disorders. [44] [45] [46] [47] Deficiency of DNase1 results in high levels of antinuclear antibody, thus contributing to the development of an SLE-like disease in humans and in mice. 44 DNase II is a lysosome-resident endonuclease and is required for digesting DNA of apoptotic cells engulfed by phagocytes or nuclei expelled from erythroid precursor cells. 45, 46 Mice with cGAS-MITA-mediated innate immune response W-W Luo and H-B Shu defects in DNase2 exhibit abnormal overproduction of type I IFNs and IFN-stimulated genes, develop severe anemia and die before birth. DNase2 −/− mice, which are depleted of type I IFN receptor, are viable but suffer from chronic arthritis after 8 weeks because of the overproduction of other cytokines, such as tumor necrosis factor-α. 48 However, deletion of cGAS or MITA in mice lacking DNase2 completely rescues the lethal autoimmune phenotypes and inflammatory disorders of DNase2 −/− mice caused by accumulating self-DNA or cGAMP. 33, 49 DNase III, also known as TREX1, is a 3′ repair exonuclease located in the ER that is required for endogenous reverse-transcribed DNA metabolism. Loss-of-function mutations of TREX1 are associated with AGS, SLE and familial chilblain lupus in humans. 50 Trex1-deficient mice exhibit markedly reduced postnatal survival because of circulatory failure caused by inflammatory myocarditis. 47 In Trex1 −/− mice crossed with mice deficient for cGAS or MITA, self-DNA or accumulated cGAMP-triggered autoimmune pathology and mortality are almost completely eliminated. 49, [51] [52] [53] In addition, defective RNase H2 may induce the accumulation of RNA:DNA hybrids that trigger chronic type I IFN and inflammatory responses, leading to AGS pathology. Recent studies have indicated that a deletion or mutation in RNase2b leads to increased expression of IFN-stimulated genes dependent on the cGAS-MITA signaling pathway. 54, 55 These findings collectively reveal a critical role of cGAS-MITA signaling in aberrant self-nucleic acid-induced lethal autoimmune phenotypes and inflammatory disorders. Consistently, several gainof-function mutations in MITA are also found in patients with an autoinflammatory disease called STING-associated vasculopathy with onset in infancy 56 and with lupus-like syndromes. 57 
REGULATION OF MITA-MEDIATED SIGNALING BY CELLULAR TRAFFICKING
Several studies have suggested that MITA is partially localized in the mitochondria and mitochondria-associated membrane, and is mostly localized in the ER in resting cells. 14, 15, 17 After activation by DNA or CDNs, MITA traffics from the ER to the Golgi apparatus and further to the perinuclear microsomes or punctate structures. 14, 23 The details of this process have not been entirely clear until recently. Earlier studies indicated that ER-localized MITA associates with the translocon-associated protein β (TRAPβ) and the translocon adapter, Sec61β, which is involved in protein translocation across the ER membrane following translation. 14,23 DNA stimulation results in the translocation of MITA from the ER to Sec5-containing endosome compartments. 23 Interestingly, exocyst complex component Sec5 was reported to recruit and activate TBK1, which is essential for IFN induction in response to RNA and DNA pathogens. 58 Consistent with these observations, knockdown of TRAPβ, Sec61β and Sec5 inhibits MITA-mediated IFN-β promoter activation. 14, 23 Brefeldin A, an ATPase inhibitor for protein transport that inhibits MITA trafficking, also prevents MITA-mediated IRF3 phosphorylation and IFN-β activation. 23, 59 These studies suggest that MITA links DNA virus-induced signaling to TBK1 activation through its translocation from the ER to the perinuclear punctate structures. Surprisingly, MITA trafficking is more complicated and well organized than we had imagined. A recent study showed that MITA traffics to the ER-Golgi intermediate compartment (ERGIC), recruits TBK1 and induces IRF3 activation upon DNA transfection, which indicates that ERGIC is an important platform for MITA activation. 60 In addition to MITA, TBK1 has also been found to traffic to perinuclear regions in DNAstimulated cells. 23 Notably, in the case of MITA deficiency, TBK1 fails to relocate to perinuclear regions after DNA stimulation, suggesting that DNA induces TBK1 trafficking in a MITA-dependent manner. 23 Similarly, another study demonstrated that the ER adapter SCAP traffics from the ER via Golgi to perinuclear microsomes after HSV-1 infection, which recruits IRF3 into MITA signaling complexes and then activates downstream signaling. 61 Collectively, DNA stimulationtriggered MITA trafficking and recruitment of downstream signaling molecules are highly ordered in a spatiotemporal manner by precise regulation across multiple membrane compartments.
Along these lines, several studies have suggested that DNA stimulation induces MITA trafficking by mechanisms involving autophagy. For example, the autophagy-related gene (Atg)9a has been reported to negatively regulate the DNA-induced immune response by inhibiting the dynamic translocation of MITA. In Atg9a-deficient cells, translocation of MITA from the Golgi apparatus to the punctate structures and the assembly of MITA and TBK1 complexes are markedly enhanced following DNA stimulation. 62 Another study indicated that knockdown of Vsp34/PI3KC3 inhibits dsDNA-induced MITA trafficking and MITA-dependent IFN-β production. 59 In addition, the Beclin-1-PI3KC3 (Vps34) core complex has been found to have a crucial role in the induction of the autophagy process by generating phosphatidylinositol 3-phosphate-rich membranes, which act as platforms for autophagy protein recruitment and autophagosome nucleation. Surprisingly, Beclin-1 has been found to negatively regulate the cGAS-MITA-mediated IFN response by repressing the enzymatic activity of cGAS. 63 Similar to MITA and TBK1, cGAS also forms predominant cytoplasmic punctate structures after DNA stimulation, indicating the relocalization of cGAS, MITA and TBK1 may be essential to the innate immune response to DNA stimulation. In addition, cGAS has been shown to be required for dsDNA simulation-induced Beclin-1-dependent autophagy. 63 Previously, several studies have also demonstrated the requirement of the STING-TBK1-induced autophagy-like response for the host defense against bacterial infection. 59, 62, [64] [65] [66] [67] Collectively, these studies suggest that the cGAS-MITA axis orchestrates IFN and autophagy pathways to optimize the efficiency of host antiviral activity in response to DNA virus.
Although a link between MITA relocalization and autophagy has been established, the mechanisms by which MITA translocation is initiated are not fully understood. Recently, inactive rhomboid protein 2 (iRhom2) has been identified as an essential component of the innate antiviral pathways against DNA viruses. Previously, it has been reported that iRhom2 has 75 In addition to K63-or K27-linked polyubiquitination, MITA undergoes K48-linked polyubiquitination. It has been shown that the ER-associated E3 ubiquitin ligase RNF5 negatively regulates virus-induced signaling by targeting K150 of MITA for K48-linked polyubiquitination and promoting its proteasome-dependent degradation after viral infection. 37 Interestingly, RNF5 also mediates K48-linked polyubiquitination and degradation of VISA, 76 which is a key adapter for RLR-mediated antiviral signaling, [77] [78] [79] [80] in a viral infectiondependent manner. Another study has demonstrated that the murine E3 ubiquitin ligase TRIM30α mediates the proteasomal degradation of MITA via K48-linked polyubiquitination at K275. 81 Notably, an ortholog of the gene encoding TRIM30α does not seem to be present in the human genome. It is possible that RNF5 fulfills the function of TRIM30α on MITAmediated signaling in human cells. Additional studies are needed to determine whether murine RNF5 catalyzes K48-linked polyubiquitination of murine MITA at K275 or K150. Adding to these observations, a recent study indicated that the ER-resident E3 ligase RNF26 catalyzes K11-linked polyubiquitination of MITA and competes with RNF5-mediated K48-linked polyubiquitination of MITA at K150, protecting MITA from subsequent degradation. 82 This is the first evidence that K11-linked polyubiquitination has important regulatory roles in the innate antiviral response. As most of the identified E3 ubiquitin ligases target MITA at K150, it is possible that various E3 ligases are recruited to the MITA complex at different phases after virus infection or in response to different types of viruses, resulting in positive or negative roles in MITAmediated signaling and balancing the activation and termination of the antiviral immune response.
Although various studies have demonstrated that MITA is regulated by different types of polyubiquitination, little is known about how it is deubiquitinated. In addition to its role in regulating MITA translocation by promoting the assembly of cGAS-MITA-mediated innate immune response W-W Luo and H-B Shu a MITA-TRAPβ complex, iRhom2 also has an important role in maintaining the stability of MITA by removing its K48-linked polyubiquitin moieties. 70 iRhom2 itself is not a deubiquitinase but rather recruits the deubiquitinase EIF3S5 to the MITA complex for efficient deubiquitination of MITA in uninfected and early infected cells, resulting in the stability of MITA and promoting activation of the innate immune response early after viral infection. 70 Further analysis has indicated that iRhom2-TRAPβ-mediated trafficking and iRhom2-EIF3S5-mediated deubiquitination of MITA are independent, suggesting that the two distinct regulatory processes of MITA functions bifurcate at iRhom2. 70 These findings suggest that iRhom2 has a critical role in the innate immune response to DNA stimulation by modulating the functions of MITA through two distinct mechanisms.
SUMOYLATION-MEDIATED REGULATION OF THE cGAS-MITA PATHWAY
Although it has been well established that MITA and other innate immune signaling components are regulated by different types of polyubiquitination, how cGAS is regulated by posttranslational modifications remains enigmatic. Small ubiquitinlike modification, called SUMOylation, is catalyzed in a similar manner as polyubiquitination. Recently, cGAS and MITA have been reported to be dynamically SUMOylated by TRIM38 before and/or after viral infection or cytosolic DNA stimulation. TRIM38 catalyzes SUMOylation of cGAS at K217 or K464 before or during the early phase of viral infection, thereby inhibiting K48-linked polyubiquitination at K271 or K464 and degradation of cGAS by unidentified E3 ubiquitin ligase(s). SUMOylation of MITA at K337 by TRIM38 facilitates its CTTmediated oligomerization and masks the adjacent 326 QEVLR 330 motif to prevent its degradation by the chaperone-mediated autophagy (CMA) pathway after viral infection. 83 The sumoylation of cGAS and MITA is therefore important for efficient onset of the innate immune response to DNA viruses. 83 It has been shown that the desumoylating enzyme SENP2 mediates the desumoylation of cGAS and MITA during the late phase of viral infection, resulting in their degradation by the ubiquitinproteasomal and CMA pathways, respectively, and the timely termination of the innate immune response to avoid immune damage. 83 Previously, SENP2 was reported to deSUMOylate IRF3 and promote its K48-linked polyubiquitination and degradation, 84 suggesting that SENP2 has a negative role in the antiviral immune response by targeting different components in the innate immune signaling pathways. Further investigation has shown that phosphorylation of MITA at S365 by TBK1 or UNC-51-like kinase ULK1/2 facilitates recruitment of SENP2 to MITA during the late phase of viral infection. These findings reveal divergent and dynamic regulatory mechanisms of the cGAS-MITA pathway by TRIM38-mediated SUMOylation and SENP2-mediated deSUMOylation, coupled with polyubiquitination and phosphorylation. However, the molecular mechanisms underlying the recruitment of SENP2 to cGAS or IRF3 remain unknown. A possible scenario is that the recruitment of SENP2 to cGAS or IRF3 is also mediated by similar events, such as phosphorylation of cGAS by Akt or IRF3 by TBK1. An additional question has been raised as to whether TRIM38 or another E3 ligase catalyzes the SUMOylation of IRF3.
REGULATION OF THE cGAS-MITA PATHWAY BY PHOSPHORYLATION AND DEPHOSPHORYLATION
MITA has been shown to be phosphorylated at several residues. Previous studies have shown that MITA is phosphorylated at S358 by TBK1 in response to Sendai virus infection, which is critical for its activation. 17 Another study found that upon cytosolic DNA stimulation, MITA is phosphorylated at multiple serine residues (S358, S353 and S379) in L929 cells, in which endogenous murine MITA was replaced with human MITA. 85 In addition, depletion of TBK1 abrogates DNAinduced MITA phosphorylation as well as the interaction between MITA and IRF3, which suggests that TBK1 mediates the phosphorylation of MITA and further promotes the interaction of MITA with IRF3. 85 Subsequent studies have also demonstrated that S358 of MITA is a direct target for TBK1 using in vitro assays, and this phosphorylation contributes to the aggregation of MITA induced by cytosolic DNA or HSV-1 infection in THP-1 cells. 86 Interestingly, it has been shown that the protein phosphatase PPM1A negatively regulates innate antiviral signaling by targeting MITA for dephosphorylation and preventing its aggregation. In addition, PPM1A directly dephosphorylates TBK1 at S172, which is important for TBK1 activation by GSK3β-mediated autophosphorylation. 86, 87 These studies suggest that TBK1-mediated phosphorylation and PPM1A-mediated dephosphorylation at S358 of MITA are important regulatory mechanisms for innate immune responses to DNA viruses.
In addition to S358, S366 of MITA is also phosphorylated by TBK1. S366 of MITA is positioned within a pLxIS (p, hydrophilic; x, nonaromatic) consensus motif that is found in MAVS, TRIF, IRF3 and IRF5. 88 cGAMP stimulation induces phosphorylation of S366 in MITA and IRF3 dimerization in wild-type but not Tbk1 −/− cells. 88 It has also been reported that MITA is phosphorylated at S366 by ULK1 after it is trafficked out of ER and activated, resulting in impairment of IRF3 activation. 59 These findings suggest that TBK1 and ULK1 phosphorylate MITA at the same residue but have opposite effects on IRF3 activation. Recently, it has been shown that although both TBK1 and ULK1 phosphorylate MITA at S366, TBK1 but not ULK1 phosphorylates IRF3 at S396, which is a hallmark of IRF3 activation. This study provides an explanation for previous reports that TBK1 and ULK1 phosphorylate MITA at the same residue but have opposite effects on the induction of downstream antiviral genes.
Recently, it has been shown that cGAS is also regulated by phosphorylation. 89 Human cGAS is phosphorylated at S305 by Akt, a residue close to the catalytic motif of cGAS. 89 This phosphorylation results in the inhibition of the cGAS-mediated innate immune response to DNA stimulation or DNA virus infection. 89 cGAS-MITA-mediated innate immune response W-W Luo and H-B Shu
REGULATION OF cGAS ACTIVITY BY GLUTAMYLATION
Glutamylation is a form of reversible post-translational modification catalyzed by glutamylases, such as TTLL (tubulin tyrosine ligase-like), enzymes that add glutamate side chains onto the g-carboxyl groups of glutamic acid residues in the sequence of target proteins. [90] [91] [92] Glutamylation was originally identified as a tubulin modification in the brain of mammals. 93 A recent study has suggested that the TTLL family members, TTLL4 and TTLL6, have important roles in cytosolic DNAtriggered immune responses by regulating cGAS activity. TTLL6-mediated polyglutamylation of cGAS at Glu272 impedes its DNA-binging ability, whereas TTLL4-mediated monoglutamylation of cGAS at E302 blocks its synthase activity. 94 The level of glutamylated cGAS, as well as the expression of TTLL4 and TTLL6 decrease rapidly after infection with HSV-1, suggesting that this process may be turned off by unknown feedback regulatory mechanisms. 94 Glutamylation is a reversible modification that can be removed by a family of cytosolic carboxypeptidases (CCPs). 90, 95, 96 It has been shown that CCP5 is responsible for hydrolyzing the glutamate chain of cGAS at E302 and that CCP6 removes the glutamate chain of cGAS at E272. 94 These observations suggest that the activity of cGAS is dynamically regulated by glutamylation and deglutamylation during DNA virus infection, highlighting a previously unknown role of glutamylation in regulation of innate immune response.
REGULATION OF cGAS AND MITA AT THE MRNA LEVEL
Although most studies have focused on regulation of cGAS and MITA at the post-translational modification level, investigations into their transcriptional regulation has recently emerged. It has been shown that both MITA and cGAS are IFNstimulated genes that are induced by IFN-I via a STAT1-binding site and two adjacent IFN-stimulated response elements in their respective promoter regions. Transcriptional induction of MITA and cGAS mediates a positive-feedback regulatory loop of CDN-triggered expression of IFN-I. 97 However, another study has demonstrated that MITA inhibits dsDNA-triggered activation of JAK-STAT1 signaling by inducing SHP1 and SHP2 phosphorylation, which mediates the negative but not positive-feedback regulation of DNA-triggered induction of IFN-I. 36 In addition, the cytosolic DNA sensor IFI16/p202, an IFN-inducible protein, has been reported to mediate downregulation of the messenger (mRNA) expression of MITA, suggesting that MITA is regulated by IFN-I via a negative feedback mechanism. 98 Recently, studies have demonstrated that the P-body protein LSm14A has an important role in innate antiviral response in DCs by regulating pre-mRNA processing of MITA. 99 It has been demonstrated that mRNA of only MITA but not cGAS, TBK1 or IRF3 is markedly reduced in Lsm14a −/− DCs. Biochemical analysis indicates that the stability of MITA mRNA and transcription of the Mita gene are not affected in Lsm14a −/− DCs. However, the mature MITA mRNA but not its pre-mRNA is downregulated in LSm14A-deficient DCs. These data suggest that LSm14A is required for maintaining the mRNA level of MITA in DCs by regulating MITA pre-mRNA processing. Consistently, results from hematopoietic-specific knockout mice suggest that LSm14A is essential for the production of serum cytokines induced by DNA viruses and for cGAMP-mediated T and B cell activation. 99 Increasing evidence has indicated that miRNAs have key roles in the regulation of the innate antiviral response. It has been demonstrated that miR-576-3p is induced by activated IRF3 and targets MITA, which triggers a feedback regulatory mechanism to reduce IFN-I expression and avoid excessive immune response following viral infection. 100 In addition to MITA, VISA and TRAF3 are also found to be targeted by miR-576-3p. 100 These studies suggest that regulation of the mRNA level of MITA via distinct mechanisms is important for the proper innate immune response.
OTHER REGULATORY MECHANISMS
Several additional proteins have been identified to regulate the cGAS-MITA signaling pathway by other regulatory mechanisms. NLRC3, a NOD-like receptor family member, was reported to negatively regulate the innate immune signaling induced by DNA stimulation. NLRC3 interacts with MITA and TBK1, breaking the association of MITA with TBK1. 101 NLRC3 has also been shown to inhibit the trafficking of MITA, although the precise mechanism remains unknown. Interestingly, two studies have shown that HIV-1 hijacks the host factor NLRX1 to inhibit the antiviral IFN response and facilitates viral spread in the early phase of infection via a similar mechanism by blocking the assembly of the MITA-TBK1 complex. 102, 103 There studies highlight pivotal roles of NLRs for both host protection and viral immune evasion.
It is known that MITA dimerization is required for its downstream signal transduction. It has been shown that the ER-resident protein ZDHHC1 positively regulates the innate immune response to DNA viruses by mediating MITA aggregation and recruitment of TBK1 and IRF3. 104 In addition to these host factors, cGAS and MITA are also targeted by various viral proteins for immune evasion, which has been reviewed elsewhere. 105, 106 CONCLUDING REMARKS AND PROSPECTS It is well accepted that the cGAS-MITA signaling axis is essential to the innate immune response to cytosolic DNA derived from pathogens, including DNA viruses, retroviruses, bacteria and parasites, as well as for the pathogenesis of autoimmune and autoinflammatory disorders induced by sensing aberrant self-DNA. Because of its importance, the cGAS-MITA signaling pathway must be precisely regulated to efficiently turn on innate immune responses to various DNA pathogens and to turn off the responses in a timely manner to avoid immune damage. In recent years, numerous studies have focused on the regulatory mechanisms of cGAS-MITA signaling and identified a number of host regulatory components. These efforts help us to understand the biochemical mechanisms of cGAS-MITA signaling, from its initiation by nucleic acid recognition to the induction of downstream antiviral cGAS-MITA-mediated innate immune response W-W Luo and H-B Shu genes. In response to DNA stimulation, the cGAS-MITA axis undergoes multiple layers of regulation, including subcellular translocation and post-translational and transcriptional regulation (Figure 1) .
Although the delineation of cGAS-MITA-dependent signaling is emerging, further in-depth studies will help us to replenish and refine this scenario. For example, similar to MITA and TBK1, cGAS was found to undergo punctate structure-like aggregation in response to DNA stimulation. However, the molecular mechanisms underlying cGAS translocation remain unclear. Various post-translational regulatory mechanisms are widely found in MITA and other innate immune components. Nevertheless, post-translational regulation of cGAS is less well defined. Recent studies have shown that cGAS is subjected to regulation by polyubiquitination, SUMOylation and phosphorylation. However, the E3 ubiquitin ligase(s) responsible for polyubiquitination of cGAS after DNA stimulation are unknown. In addition, the spatial and temporal regulation of the various modifications of cGAS and MITA needs to be further characterized.
In humans with viral infections, the immune system faces more complicated circumstances. Most microbes contain multiple distinct PAMPs that trigger different PRR pathways. Even a single PAMP, such as DNA, may induce multiple distinct innate immune signaling pathways. How the cGAS-MITA pathway cross-talks with other pathways is an intriguing question for future investigation. The cGAS-MITA signaling pathway is important to the innate immune response to various DNA pathogens and certain RNA viruses. How these different pathogens antagonize the cGAS-MITA pathway for immune evasion will also be an interesting question for future studies.
In conclusion, thorough investigation into the mechanisms of cGAS-MITA-mediated signaling will contribute to our understanding of how innate immune responses to DNA pathogens are optimally activated at the early phase of infection and then turned off in a timely manner in the late phase of infection and will provide new strategies and methods for effective control and treatment of infectious and autoimmune diseases. 
